Media Summary: In this segment, Andrew Tustian, the senior director of preclinical manufacturing and During this session, our presenters will highlight This expert panel from the 2023 CGT Summit hosted by Charles River Laboratories explores the full

Aav Upstream Process Development Innovations - Detailed Analysis & Overview

In this segment, Andrew Tustian, the senior director of preclinical manufacturing and During this session, our presenters will highlight This expert panel from the 2023 CGT Summit hosted by Charles River Laboratories explores the full Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, discusses strategies for safe and effective viral vector ... Presented By: Leisha Kopp Speaker Biography: Leisha Kopp is an Applications Scientist at Mirus Bio LLC, a biotech company ... We often hear that gene therapies are complex and require a lot of time and money to make. But what does that really mean?

Join our educational webinar and learn how recent "Efficient and Scalable GMP Manufacture of

Photo Gallery

AAV Upstream Process Development Innovations
Scalable AAV manufacturing: addressing challenges across the workflow
Get Lab Ready With Me - Upstream Process Development
Enabling Custom Solutions for Downstream Processing for Future Therapies: AAV Case Study
AAV Gene Therapy: From Discovery to Commercialization | CGT Summit 2023
From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment Step
Basics of AAV Gene Therapy
Innovations in viral vector development
How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy Manufacturing
Lunch & Learn: How AAV Vectors Are Made
Innovations in viral vector development, scale up and production webinar
Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers
View Detailed Profile
AAV Upstream Process Development Innovations

AAV Upstream Process Development Innovations

In this segment, Andrew Tustian, the senior director of preclinical manufacturing and

Scalable AAV manufacturing: addressing challenges across the workflow

Scalable AAV manufacturing: addressing challenges across the workflow

During this session, our presenters will highlight

Get Lab Ready With Me - Upstream Process Development

Get Lab Ready With Me - Upstream Process Development

Get Lab Ready with Eliza Cargin in our

Enabling Custom Solutions for Downstream Processing for Future Therapies: AAV Case Study

Enabling Custom Solutions for Downstream Processing for Future Therapies: AAV Case Study

BioProcess

AAV Gene Therapy: From Discovery to Commercialization | CGT Summit 2023

AAV Gene Therapy: From Discovery to Commercialization | CGT Summit 2023

This expert panel from the 2023 CGT Summit hosted by Charles River Laboratories explores the full

From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment Step

From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment Step

Adeno-associated viruses (

Basics of AAV Gene Therapy

Basics of AAV Gene Therapy

Basics of

Innovations in viral vector development

Innovations in viral vector development

Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, discusses strategies for safe and effective viral vector ...

How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy Manufacturing

How LV and AAV Transfection Platforms will Shape the Future of Gene Therapy Manufacturing

Presented By: Leisha Kopp Speaker Biography: Leisha Kopp is an Applications Scientist at Mirus Bio LLC, a biotech company ...

Lunch & Learn: How AAV Vectors Are Made

Lunch & Learn: How AAV Vectors Are Made

We often hear that gene therapies are complex and require a lot of time and money to make. But what does that really mean?

Innovations in viral vector development, scale up and production webinar

Innovations in viral vector development, scale up and production webinar

Join our educational webinar and learn how recent

Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers

Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers

"Efficient and Scalable GMP Manufacture of

Overcoming Challenges in AAV and LV Viral Vector Manufacturing

Overcoming Challenges in AAV and LV Viral Vector Manufacturing

Overcoming Challenges in